SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

A full strategic pivot to an AI/HPC data center infrastructure provider, marked by its rebrand to "Cipher Digital," is driving significant discussion for Cipher Mining. Bullish investors are highlighting billions in contracted revenue with hyperscalers like Amazon and Google, anticipated imminent new deals, and strong institutional financing as key drivers for its decoupling from Bitcoin's volatility.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Vir Biotechnology is trending following a major collaboration deal with Astellas Pharma for its prostate cancer asset, which includes significant upfront and milestone payments, coupled with encouraging Phase 1 trial data. Community discussion is split between bullish sentiment for a long-term breakthrough and skepticism anticipating a typical biotech 'sell the news' reaction due to the early development stage.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending following mixed earnings that highlighted strong subscriber growth but raised concerns with soft forward guidance and increasing regulatory scrutiny surrounding its GLP-1 weight-loss business. This has ignited a fierce debate within the community, with many anticipating a short squeeze due to high short interest, while others warn of further downside from mounting legal and competitive pressures.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending as the market keenly debates the disruptive potential of Anthropic's Claude Code on legacy COBOL modernization, a key service for Big Blue, which triggered a notable market cap decline. Community discussion centers on whether this is an overreaction, given IBM's existing AI solutions and its partnership with Anthropic, or if it signals a broader shift in traditional IT services.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

Rich Sparkle Holdings (ANPA) is trending due to its recent acquisition of TikTok icon Khaby Lame's core company, propelling it into the e-commerce live-streaming sector. This move has generated significant speculative interest and extreme volatility, with community discussion polarized between potential for a "Hong Kong low float" squeeze and concerns over massive share dilution and the company's valuation relative to its revenue.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk (SNDK) is trending as investors rally against a recent Citron Research short report, widely dismissed by the community who emphasize robust demand for AI-driven memory and rising flash prices. This strong bullish conviction in the company's semiconductor position is fueling calls for a short squeeze.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is surging after reporting significant revenue growth and securing international approvals for its ANKTIVA immunotherapy, with its CEO discussing a multi-year expansion roadmap for various cancer indications. The community is actively debating a potential short squeeze, given the high short interest, as the company transitions into a commercial-stage leader in cancer treatment.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Kratos Defense is trending as investors react to its recent robust earnings beat and new contract awards across hypersonics, drones, and satellite defense, fueling community discussion around its strong market position amid heightened global tensions and anticipated long-term defense spending.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending as the community eagerly awaits its upcoming earnings report, widely expected to mark its 18th consecutive beat and a significant step towards GAAP profitability, even amidst broader software sector concerns regarding AI disruption impacting market sentiment.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy (BE) is trending following an impressive Q4 earnings beat and robust 2026 guidance, driven by a surging product backlog and massive demand from the AI data center industry. The community expresses high conviction for its long-term growth as a critical power infrastructure provider, despite acknowledging its extreme volatility and high valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Glaukos (NYSE:GKOS) Director Sells 15,000 Shares of Stock

Glaukos Corporation (NYSE:GKOS - Get Free Report) Director Aimee Weisner sold 15,000 shares of the firm's stock in a transaction dated Thursday, February 19th. The stock was sold at an average price...

Glaukos Corporation (NYSE:GKOS) Given Average Recommendation of "Moderate Buy" by Brokerages

Glaukos Corporation (NYSE:GKOS - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the sixteen brokerages that are covering the company, Marketbeat.com reports. Two...

Glaukos (NYSE:GKOS) Cut to "Hold" at Wall Street Zen

Wall Street Zen lowered shares of Glaukos from a "buy" rating to a "hold" rating in a report on Saturday...

Glaukos (NYSE:GKOS) Trading 8.4% Higher - What's Next?

Glaukos (NYSE:GKOS) Stock Price Up 8.4% - Here's Why...

Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook

GKOS posts 36% Q4 revenue jump, raises 2026 sales outlook to $600-$620M as iDose TR and Epioxa fuel growth despite wider loss.

These Analysts Boost Their Forecasts On Glaukos Following Q4 Results

BTIG Research Reaffirms Buy Rating for Glaukos (NYSE:GKOS)

BTIG Research reissued a "buy" rating and issued a $131.00 price target on shares of Glaukos in a report on Wednesday...

Glaukos Q4 Earnings Call Highlights

Glaukos (NYSE:GKOS) reported record fourth-quarter and full-year 2025 results and reaffirmed its 2026 revenue outlook, with management pointing to continued momentum in iDose TR for glaucoma and the...

Glaukos (GKOS) Q4 2025 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Glaukos (GKOS) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Glaukos (GKOS) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.27	--	--	N/A
Q4 '25	-$0.20	-$0.28	-43.08%	MISSED
Q3 '25	-$0.26	-$0.16	38.60%	BEAT
Q2 '25	-$0.26	-$0.24	9.16%	BEAT
Q1 '25	-$0.35	-$0.22	36.84%	BEAT

GKOS
Glaukos Corporation

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest GKOS News

GKOSGlaukos Corporation